Medtronic Unveils EVARpro Suite of Services to Streamline Clinical Use
New Offering Improves Pre-Case Planning, Procedural Efficiency and Patient Follow-Up
Improving the efficiency of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today introduced EVARpro, a suite of value-added services for physicians who specialize in the minimally invasive treatment of aortic aneurysms and injuries with the company's stent grafts.
Available exclusively to Medtronic customers, EVARpro is comprised of CTeXpress and 3D Recon, which are integrated online, and StentGraftTracker. All three services combine to improve pre-case planning, procedural efficiency and patient follow-up.
"EVARpro simplifies the entire treatment process, while also giving physicians more information for treatment decisions," said Tony Semedo, vice president and general manager of Medtronic's Endovascular Innovations business. "As the only manufacturer of aortic stent grafts that delivers value-added services spanning the entire treatment continuum, Medtronic offers EVARpro to support physicians in their clinical decision-making. To deliver these services, Medtronic has partnered with the industry leaders Intelemage for remote medical image transfer and Vital Images for advanced visualization."
EVARpro is a collaboration with Intelemage, developer of CTeXpress, and Vital Images, developer of 3D Recon.
Utilized during the planning of abdominal and thoracic stent graft procedures, CTeXpress allows for the remote transfer and storage of computed tomography (CT) images of aortic aneurysms between physicians and Medtronic field representatives for timely consultation and future reference. With EVARpro, CTeXpress provides direct access to the 3D Recon software so that two-dimensional images can be easily converted into a three-dimensional (3D) image in one step via the integrated software online.
Previously available only on Medtronic field representative laptops, 3D Recon is now available online as well to provide physicians greater accessibility to 3D images of their patients' aortic anatomies. 3D Recon allows for advanced visualization of the aneurysm, as well as measurement of aneurysm length, diameter and angulation, so that the physician can recommend the most appropriate device combination for the procedure.
Combined with CTeXpress and 3D Recon, StentGraftTracker completes EVARpro. This online application enables physicians to track follow-up visits for patients with Medtronic stent grafts, thereby spanning the endovascular treatment continuum.
Medtronic is committed to advancing the treatment of cardiovascular disease through collaboration with leading clinicians, researchers and scientists worldwide.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health and extending life for millions of people around the world.